Invention Grant
![Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases](/docs/US/2018-09-04/US10065966B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
-
Application No.: US15604786Application Date: 2017-05-25
-
Publication No.: US10065966B2Publication Date: 2018-09-04
- Inventor: Laura Akullian D'Agostino , Robert Tjin Tham Sjin , Deqiang Niu , Joseph John McDonald , Zhendong Zhu , Haibo Liu , Hormoz Mazdiyasni , Russell C. Petter , Juswinder Singh , Matthieu Barrague , Alexandre Gross , Mark Munson , Darren Harvey , Andrew Scholte , Sachin Maniar
- Applicant: Celgene CAR LLC , Sanofi
- Applicant Address: BM Pembroke FR Paris
- Assignee: Celgene CAR LLC,Sanofi
- Current Assignee: Celgene CAR LLC,Sanofi
- Current Assignee Address: BM Pembroke FR Paris
- Agency: Choate, Hall & Stewart LLP
- Agent Kristen C. Buteau; Nicholas J. Pace
- Priority: EP14305361 20140313
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D487/04 ; C07D239/80 ; C07D519/00
![Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases](/abs-image/US/2018/09/04/US10065966B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides compounds of formula I-h: useful as inhibitors of protein kinases, pharmaceutically acceptable compositions thereof, and methods of using the same.
Public/Granted literature
- US20170267685A1 HETEROARYL COMPOUNDS AND USES THEREOF Public/Granted day:2017-09-21
Information query
